Tirzepatide emerges a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://brendaxiwg590531.widblog.com/95427973/tirzepatide-a-game-changer-for-type-2-diabetes